Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab

Chun Yu Liu; Hao Wei Teng; Jiing Feng Lirng; Tzeon Jye Chiou; Po Min Chen; Liang Tsai Hsiao

doi:10.1080/10428190802311375

Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab

Chun Yu Liu, Hao Wei Teng, Jiing Feng Lirng, Tzeon Jye Chiou, Po Min Chen, Liang Tsai Hsiao

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2018-2021
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	49
Issue number	10
DOIs	https://doi.org/10.1080/10428190802311375
Publication status	Published - 2008
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428190802311375

Cite this

Liu, C. Y., Teng, H. W., Lirng, J. F., Chiou, T. J., Chen, P. M., & Hsiao, L. T. (2008). Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab. Leukemia and Lymphoma, 49(10), 2018-2021. https://doi.org/10.1080/10428190802311375

Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab. / Liu, Chun Yu; Teng, Hao Wei; Lirng, Jiing Feng et al.
In: Leukemia and Lymphoma, Vol. 49, No. 10, 2008, p. 2018-2021.

Research output: Contribution to journal › Article › peer-review

Liu, CY, Teng, HW, Lirng, JF, Chiou, TJ, Chen, PM & Hsiao, LT 2008, 'Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab', Leukemia and Lymphoma, vol. 49, no. 10, pp. 2018-2021. https://doi.org/10.1080/10428190802311375

@article{4369cfe07d714446b8236922f857fe83,

title = "Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab",

author = "Liu, {Chun Yu} and Teng, {Hao Wei} and Lirng, {Jiing Feng} and Chiou, {Tzeon Jye} and Chen, {Po Min} and Hsiao, {Liang Tsai}",

year = "2008",

doi = "10.1080/10428190802311375",

language = "English",

volume = "49",

pages = "2018--2021",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "10",

}

TY - JOUR

T1 - Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab

AU - Liu, Chun Yu

AU - Teng, Hao Wei

AU - Lirng, Jiing Feng

AU - Chiou, Tzeon Jye

AU - Chen, Po Min

AU - Hsiao, Liang Tsai

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=55049116646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55049116646&partnerID=8YFLogxK

U2 - 10.1080/10428190802311375

DO - 10.1080/10428190802311375

M3 - Article

C2 - 18728965

AN - SCOPUS:55049116646

SN - 1042-8194

VL - 49

SP - 2018

EP - 2021

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 10

ER -

Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this